Utah Medical Products, Inc.
UTMD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $40,903 | $50,224 | $52,281 | $49,054 |
| % Growth | -18.6% | -3.9% | 6.6% | – |
| Cost of Goods Sold | $16,760 | $20,186 | $20,085 | $18,137 |
| Gross Profit | $24,143 | $30,038 | $32,196 | $30,917 |
| % Margin | 59% | 59.8% | 61.6% | 63% |
| R&D Expenses | $813 | $560 | $493 | $526 |
| G&A Expenses | $3,666 | $11,016 | $10,406 | $10,097 |
| SG&A Expenses | $5,567 | $12,701 | $11,913 | $11,511 |
| Sales & Mktg Exp. | $1,901 | $1,685 | $1,507 | $1,414 |
| Other Operating Expenses | $4,169 | $0 | $0 | $0 |
| Operating Expenses | $10,549 | $13,261 | $12,406 | $12,037 |
| Operating Income | $13,594 | $16,777 | $19,790 | $18,880 |
| % Margin | 33.2% | 33.4% | 37.9% | 38.5% |
| Other Income/Exp. Net | $3,208 | $3,312 | $869 | $181 |
| Pre-Tax Income | $16,802 | $20,089 | $20,659 | $19,061 |
| Tax Expense | $2,928 | $3,454 | $4,186 | $4,273 |
| Net Income | $13,874 | $16,635 | $16,473 | $14,788 |
| % Margin | 33.9% | 33.1% | 31.5% | 30.1% |
| EPS | 3.96 | 4.57 | 4.53 | 4.05 |
| % Growth | -13.3% | 0.9% | 11.9% | – |
| EPS Diluted | 3.96 | 4.57 | 4.52 | 4.04 |
| Weighted Avg Shares Out | 3,503 | 3,637 | 3,637 | 3,647 |
| Weighted Avg Shares Out Dil | 3,503 | 3,637 | 3,643 | 3,660 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3,367 | $0 | $661 | $166 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $2,771 | $6,368 | $7,082 | $7,284 |
| EBITDA | $16,440 | $24,752 | $26,872 | $26,164 |
| % Margin | 40.2% | 49.3% | 51.4% | 53.3% |